Answers are grounded in this paper and cite their sources.
Squalene synthase (SS) is the first committed enzyme for cholesterol biosynthesis, located at a branch point in the mevalonate pathway. To examine the role of SS in the overall cholesterol metabolism, we transiently overexpressed mouse SS in the livers of mice using adenovirus-mediated gene transfer. Overexpression of SS increased de novo cholesterol biosynthesis with increased 3-hydroxy-3-methyglutaryl-CoA (HMG-CoA) reductase activity, in spite of the downregulation of its own mRNA expression. Furthermore, overexpression of SS increased plasma concentrations of LDL, irrespective of the presence of functional LDL receptor (LDLR). Thus, the hypercholesterolemia is primarily caused by increased hepatic production of cholesterol-rich VLDL, as demonstrated by the increases in plasma cholesterol levels after intravenous injection of Triton WR1339. mRNA expression of LDLR was decreased, suggesting that defective LDL clearance contributed to the development of hypercholesterolemia. Curiously, the liver was enlarged, with a larger number of Ki-67-positive cells. These results demonstrate that transient upregulation of SS stimulates cholesterol biosynthesis as well as lipoprotein production, providing the first in vivo evidence that SS plays a regulatory role in cholesterol metabolism through modulation of HMG-CoA reductase activity and cholesterol biosynthesis. Squalene synthase (SS) is the first committed enzyme for cholesterol biosynthesis, located at a branch point in the mevalonate pathway. To examine the role of SS in the overall cholesterol metabolism, we transiently overexpressed mouse SS in the livers of mice using adenovirus-mediated gene transfer. Overexpression of SS increased de novo cholesterol biosynthesis with increased 3-hydroxy-3-methyglutaryl-CoA (HMG-CoA) reductase activity, in spite of the downregulation of its own mRNA expression. Furthermore, overexpression of SS increased plasma concentrations of LDL, irrespective of the presence of functional LDL receptor (LDLR). Thus, the hypercholesterolemia is primarily caused by increased hepatic production of cholesterol-rich VLDL, as demonstrated by the increases in plasma cholesterol levels after intravenous injection of Triton WR1339. mRNA expression of LDLR was decreased, suggesting that defective LDL clearance contributed to the development of hypercholesterolemia. Curiously, the liver was enlarged, with a larger number of Ki-67-positive cells. These results demonstrate that transient upregulation of SS stimulates cholesterol biosynthesis as well as lipoprotein production, providing the first in vivo evidence that SS plays a regulatory role in cholesterol metabolism through modulation of HMG-CoA reductase activity and cholesterol biosynthesis. Cholesterol biosynthesis is subject to tight regulation by a multivalent feedback mechanism at both the transcriptional and the posttranscriptional level (1Goldstein J.L. Brown M.S. Regulation of the mevalonate pathway..Nature. 1990; 343: 425-430Crossref PubMed Scopus (4537) Google Scholar). The transcriptional regulation is mediated through the action of sterol-regulatory element binding proteins (SREBPs), membrane-bound transcription factors that enhance transcription of genes encoding cholesterol biosynthetic enzymes and the LDL receptor (LDLR) (2Brown M.S. Ye J. Rawson R.B. Goldstein J.L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans..Cell. 2000; 100: 391-398Abstract Full Text Full Text PDF PubMed Scopus (1148) Google Scholar). The translational regulation of 3-hydroxy-3-methyglutaryl-CoA (HMG-CoA) reductase (EC1.1.1.34), the rate-limiting enzyme in cholesterol biosynthesis, is mediated by nonsterol mevalonate-derived isoprenoids, which act by an undefined mechanism (3Nakanishi M. Goldstein J.L. Brown M.S. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme..J. Biol. Chem. 1988; 263: 8929-8937Abstract Full Text PDF PubMed Google Scholar). Its degradation is regulated by both sterols and nonsterol end products of mevalonate metabolism (4Roitelman J. Simoni R.D. Distinct sterol and nonsterol signals for the regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase..J. Biol. Chem. 1992; 267: 25264-25273Abstract Full Text PDF PubMed Google Scholar, 5Inoue S. Simoni R.D. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase and T cell receptor alpha subunit are differentially degraded in the endoplasmic reticulum..J. Biol. Chem. 1992; 267: 9080-9086Abstract Full Text PDF PubMed Google Scholar). The sterol-regulated degradation of HMG-CoA reductase is mediated by the binding of a pair of endoplasmic reticulum (ER) retention proteins called Insig-1 and Insig-2 to the sterol-sensing domain in membrane-spanning segments of HMG-CoA reductase (6Sever N. Song B.L. Yabe D. Goldstein J.L. Brown M.S. DeBose-Boyd R.A. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol..J. Biol. Chem. 2003; 278: 52479-52490Abstract Full Text Full Text PDF PubMed Scopus (238) Google Scholar, 7Sever N. Yang T. Brown M.S. Goldstein J.L. DeBose-Boyd R.A. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain..Mol. Cell. 2003; 11: 25-33Abstract Full Text Full Text PDF PubMed Scopus (283) Google Scholar). Inhibition of cholesterol biosynthesis in the liver by using inhibitors of HMG-CoA reductase, collectively called statins, is a widely used strategy for preventing heart attacks by lowering plasma cholesterol. However, statins have limited effects (8Grundy S.M. Cleeman J.I. Merz C.N. Brewer Jr., H.B. Clark L.T. Hunninghake D.B. Pasternak R.C. Smith Jr., S.C. Stone N.J. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines..Arterioscler. Thromb. Vasc. Biol. 2004; 24: e149-e161Crossref PubMed Google Scholar), partly because the deficiency of mevalonate-derived products following the inhibition of HMG-CoA reductase activity leads to a compensatory increase in HMG-CoA reductase protein, invoking the need for higher doses of statins (9Kita T. Brown M.S. Goldstein J.L. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase..J. Clin. Invest. 1980; 66: 1094-1100Crossref PubMed Scopus (264) Google Scholar), and to occasional severe adverse effects, such as rhabdomyolysis (10Thompson P.D. Clarkson P. Karas R.H. Statin-associated myopathy..J. Am. Med. Assoc. 2003; 289: 1681-1690Crossref PubMed Scopus (1228) Google Scholar). Therefore, exploration of another target for the inhibition of cholesterol biosynthesis is needed. Squalene synthase (SS, or farnesyl-diphosphate:farnesyl-diphosphate farnesyltransferase, EC2.5.1.21) catalyzes the reductive head-to-head condensation of two molecules of farnesyl diphosphate to form squalene, the first specific intermediate in the cholesterol biosynthetic pathway (11Shechter I. Klinger E. Rucker M.L. Engstrom R.G. Spirito J.A. Islam M.A. Boettcher B.R. Weinstein D.B. Solubilization, purification, and characterization of a truncated form of rat hepatic squalene synthetase..J. Biol. Chem. 1992; 267: 8628-8635Abstract Full Text PDF PubMed Google Scholar, 12McKenzie T.L. Jiang G. Straubhaar J.R. Conrad D.G. Shechter I. Molecular cloning, expression, and characterization of the cDNA for the rat hepatic squalene synthase..J. Biol. Chem. 1992; 267: 21368-21374Abstract Full Text PDF PubMed Google Scholar). SS is unique among other enzymes in cholesterol biosynthesis in that, in addition to the sterol-mediated transcriptional control through the action of SREBPs (13Guan G. Dai P.H. Osborne T.F. Kim J.B. Shechter I. Multiple sequence elements are involved in the transcriptional regulation of the human squalene synthase gene..J. Biol. Chem. 1997; 272: 10295-10302Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar), expression of the SS gene is regulated by lipopolysaccharide, which potently inhibits SS, whereas it stimulates HMG-CoA reductase expression (14Memon R.A. Shechter I. Moser A.H. Shigenaga J.K. Grunfeld C. Feingold K.R. Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters..J. Lipid Res. 1997; 38: 1620-1629Abstract Full Text PDF PubMed Google Scholar). SS is an attractive target for cholesterol-lowering therapy, because the inhibition of this step theoretically may not perturb the nonsterol pathway. Indeed, several potent SS inhibitors successfully lower plasma cholesterol levels without the potential limitations reported for statins (15Baxter A. Fitzgerald B.J. Hutson J.L. McCarthy A.D. Motteram J.M. Ross B.C. Sapra M. Snowden M.A. Watson N.S. Williams R.J. et al.Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo..J. Biol. Chem. 1992; 267: 11705-11708Abstract Full Text PDF PubMed Google Scholar, 16Hiyoshi H. Yanagimachi M. Ito M. Ohtsuka I. Yoshida I. Saeki T. Tanaka H. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: with 3-hydroxy-3-methylglutaryl-CoA reductase Lipid Res. 2000; Full Text Full Text PDF PubMed Google Scholar, T. E. H. of a squalene synthase inhibitor, in vivo and in J. 2003; PubMed Scopus Google Scholar). To the role of SS in cholesterol metabolism, we have SS SS mice and and severe of development and defective that SS is for of the S. J. H. T. S. N. et and defective in mice squalene synthase..J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). mice SS in the liver with plasma lipoprotein and to from of These in HMG-CoA reductase HMG-CoA mice and HMG-CoA mice in lipoprotein J. T. H. M. S. H. N. et caused by of the 3-hydroxy-3-methylglutaryl-CoA reductase gene..J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). However, the role of SS in cholesterol metabolism in liver To the role of SS in overall cholesterol metabolism in vivo in we have used adenovirus-mediated gene to SS in the liver and have in hepatic cholesterol biosynthesis and plasma lipoprotein in that increased SS activity in liver leads to increased cholesterol as well as of cholesterol-rich providing the first in vivo evidence that SS plays a regulatory role in the development of hypercholesterolemia. that SS cDNA the control of the as was using the cDNA by from mouse liver as Smith P. J.M. gene and expression of human in Clin. Invest. 1997; 100: PubMed Scopus Google Scholar, H. J. N. T. S. M. N. et of cholesterol from by adenovirus-mediated gene of Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The in and by The in in at of to of and at mice and LDLR mice S. Brown M.S. Goldstein J.L. R.D. J. in lipoprotein receptor mice and its by adenovirus-mediated gene Clin. Invest. PubMed Scopus Google that the from and and for to the of the of the of and with and to cholesterol with of or after was of from the of in and at was from livers with of was and cDNA was using of gene with the sequence to the The specific for SS, HMG-CoA reductase, and as J. Goldstein J.L. Brown M.S. in livers of mice with PubMed Scopus Google the from The of by using the mRNA was used as the in a and and at for at The at for at and the a in the and in at The was used for as H. J. N. T. S. M. N. et of cholesterol from by adenovirus-mediated gene of Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), using an that was by with sequence of mouse of HMG-CoA reductase, we and the liver as by et N. Yang T. Brown M.S. Goldstein J.L. DeBose-Boyd R.A. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain..Mol. Cell. 2003; 11: 25-33Abstract Full Text Full Text PDF PubMed Scopus (283) Google and used from and from at of at was as and in at SS to a of et S. J. H. T. S. N. et and defective in mice squalene synthase..J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, R.J. Regulation of squalene activity in rat by Res. PubMed Scopus Google Scholar). the in of a and at for The was by the addition of of and of the and The was used for the of the in the squalene levels of cholesterol and using and by as H. T. J. T. S. et of and in mice with Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar), and the cholesterol in lipoprotein with in and with and was using rat was by end using the in to the The number of for with or was in of from at a of from by the of and J. M. A for the and of from Biol. Chem. Full Text PDF PubMed Google Scholar). was by to a of and The of and cholesterol in in Lipid Res. Full Text PDF PubMed Google with the that Triton was used of was using a proteins as HMG-CoA reductase as (9Kita T. Brown M.S. Goldstein J.L. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase..J. Clin. Invest. 1980; 66: 1094-1100Crossref PubMed Scopus (264) Google Scholar). the in of a and at for The was by the addition of of and for another at to the mevalonate The was by and using as an HMG-CoA reductase activity is as of of after of to cholesterol in the liver was the as S. J. H. T. S. N. et and defective in mice squalene synthase..J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, J. T. H. M. S. H. N. et caused by of the 3-hydroxy-3-methylglutaryl-CoA reductase gene..J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar, P. M. of a novel inhibitor on cholesterol biosynthesis and metabolism in vivo..J. Lipid Res. 1997; 38: Full Text PDF PubMed Google Scholar). and and with of and the liver was of the liver and the sterols for the of The results as of of Cholesterol biosynthesis in was as H. Brown M.S. Goldstein J.L. of LDL receptor gene in mice from production of Clin. Invest. PubMed Scopus Google Scholar, N. M. N. T. H. factor, which stimulates the of squalene to is a squalene and cholesterol PubMed Scopus Google Scholar). in and serum and on at a of 1, of or was at the was to a of for the was and The by of by of by by The of squalene, and in the and in the was by and The was by the was in A and and at for at The and used for the activity in was by the of of the to et H. T. J. T. S. et of and in mice with Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). of or cholesterol in vivo by the intravenous of Triton as T. T. A. J.L. of in human lipoprotein with increased and on the Clin. Invest. 1992; PubMed Scopus Google Scholar). levels of or cholesterol at 1, and after the of plasma to to lipoprotein using for of plasma was with of and at for at was from the by and with a and at for at The was used as the was as and used as the and the was used as the are as and with or with for injection of an increase in mRNA expression of mouse SS in the liver as with mouse SS was in liver of mice SS increased in the by of in the by and by and by and by and by and by and by and by and by and by and by and by and by and by and by and after intravenous injection of mice was from the livers and used for are as CoA reductase, 3-hydroxy-3-methyglutaryl-CoA sterol-regulatory element binding LDL cholesterol binding by and by and in a after intravenous injection of mice was from the livers and used for are as CoA reductase, 3-hydroxy-3-methyglutaryl-CoA sterol-regulatory element binding LDL cholesterol binding To the overexpressed SS increased cholesterol we the of cholesterol from in the liver the of as a for cholesterol biosynthesis several limitations to the of the results J.M. of of cholesterol using Lipid Res. Full Text PDF PubMed Google Scholar), we that overexpression of SS is to other potential factors such as of by the of cholesterol was increased that HMG-CoA reductase is the rate-limiting enzyme of cholesterol we the of HMG-CoA reductase in the of the liver was a increase in the HMG-CoA reductase in the mice with To the increase in the HMG-CoA reductase was with of the mRNA expression, we of HMG-CoA reductase with other enzymes in the cholesterol pathway The hepatic mRNA level of HMG-CoA reductase was decreased, by in the that the increased activity was at posttranscriptional the mRNA expression of enzymes the of HMG-CoA reductase, such as squalene and was in the mice by and To the expression of HMG-CoA reductase in the liver we we to HMG-CoA reductase expression by using two we to a that to HMG-CoA reductase not To the increased cholesterol in the liver SS hepatic cholesterol we in the liver The of the liver was increased by in mice with Cholesterol of not the and whereas of by in Thus, cholesterol in the liver was increased in to the increase in liver To the for the in we and of the and The number of Ki-67-positive which are with cell activity J. H. H. of a mouse with a human with cell J. PubMed Scopus Google Scholar), was increased in the livers of mice with mice whereas the number of was not the and These results that overexpression of SS stimulates cell of to of the after intravenous injection of mice from the livers by the of and and are as in a after intravenous injection of mice from the livers by the of and and are as lipoprotein after the injection of the mice and cholesterol levels by in mice with whereas in plasma levels of or lipoprotein that and levels increased by and in plasma and in or LDLR and after intravenous injection of mice or LDL receptor mice was after a was to lipoprotein plasma was used to lipoprotein for are as in a after intravenous injection of mice or LDL receptor mice was after a was to lipoprotein plasma was used to lipoprotein for are as To the hepatic overexpression of SS to we hepatic of increases in plasma cholesterol levels after the injection of Triton increased in mice with mice whereas in plasma levels not the two These results that the increase in plasma levels primarily from the of cholesterol-rich from the Indeed, the of from mice was higher that of from mice at after the injection of Triton Cholesterol in the not increase at after the injection of Triton from to from to Thus, the of increased of LDL to the development of hypercholesterolemia was with the production of cholesterol-rich VLDL, in the liver by However, mRNA expression levels of or in mice in and and after intravenous injection of Triton by and by and by and by and after intravenous injection of or Triton was was and after the was to of protein, and cholesterol are as by and in a after intravenous injection of or Triton was was and after the was to of protein, and cholesterol are as is that increased cholesterol the expression of the pathway for LDL and the plasma clearance of To this we mRNA expression of LDLR in the was by in the mice with the mice Cholesterol from the liver as The mRNA level of cholesterol the rate-limiting enzyme for was not increased Cholesterol from the liver for However, mRNA expression of was by of cholesterol-rich as a of hypercholesterolemia was by an in which was LDLR the of plasma cholesterol levels are primarily by the production because the in the LDL clearance is levels increased by lipoprotein that cholesterol was increased in the To the that the overexpression of SS is with increased cholesterol and we in using with or was to the and the for from the and and the the sterols and after by larger of cholesterol the control with of was Furthermore, of cholesterol and the was stimulated in in cells. the we that overexpression of SS in the liver increased cholesterol biosynthesis and which is the first in vivo evidence that SS plays a regulatory role in cholesterol metabolism, and is a of by that SS inhibitors cholesterol-lowering activity primarily through inhibition of hepatic production H. Yanagimachi M. Ito M. Ohtsuka I. Yoshida I. Saeki T. Tanaka H. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: with 3-hydroxy-3-methylglutaryl-CoA reductase Lipid Res. 2000; Full Text Full Text PDF PubMed Google Scholar, T. E. H. of a squalene synthase inhibitor, in vivo and in J. 2003; PubMed Scopus Google Scholar, T. H. H. H. a novel squalene synthase inhibitor, biosynthesis and in J. 2003; PubMed Scopus Google Scholar). in the are as HMG-CoA reductase activity is in spite of downregulation of its own mRNA expression. of cholesterol-rich and downregulation of LDLR are for the development of hypercholesterolemia. cholesterol is with to increased of of enzymes in the cholesterol the enzymes of SS, such as squalene and are The mRNA expression of enzymes in the cholesterol biosynthetic such as HMG-CoA reductase, squalene and was The downregulation of genes mediated through a feedback regulation by the end which was by the liver The downregulation of the genes for squalene and that are other rate-limiting in the cholesterol biosynthetic pathway cholesterol biosynthesis was increased in spite of the overall downregulation of genes in the cholesterol biosynthetic pathway. by an increase in HMG-CoA reductase activity, the rate-limiting enzyme in cholesterol biosynthesis. The of HMG-CoA reductase activity through its posttranscriptional both translation and degradation of HMG-CoA reductase are subject to feedback regulation by nonsterol mevalonate as the of increased activity of SS, of the mevalonate may to squalene, for nonsterol such as diphosphate and farnesyl this it is that translation of HMG-CoA reductase is increased and that its degradation is because of as the of for the degradation of A reductase..J. Biol. Chem. Full Text PDF PubMed Google Scholar, Simoni R.D. as a of HMG-CoA reductase characterization and role of farnesyl 1997; PubMed Scopus Google (6Sever N. Song B.L. Yabe D. Goldstein J.L. Brown M.S. DeBose-Boyd R.A. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol..J. Biol. Chem. 2003; 278: 52479-52490Abstract Full Text Full Text PDF PubMed Scopus (238) Google degradation of this To this we need to examine the of HMG-CoA reductase and the of we to HMG-CoA reductase in the liver by we the and used two HMG-CoA reductase. of cholesterol the HMG-CoA reductase to a level the G. H. Goldstein J.L. Brown M.S. regulation of cholesterol in mice mediated by Clin. Invest. PubMed Scopus Google Scholar). A deficiency of mevalonate may the upregulation of HMG-CoA reductase in from mevalonate HMG-CoA reductase activity is increased by the of the increases in its expression level S.M. M.S. R.J. Regulation of biosynthesis in from mevalonate Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). addition to the of in the cholesterol biosynthetic to the pathway regulated by a that of and to other are two potential for the hypercholesterolemia in mice with of cholesterol-rich and defective plasma clearance of of the of cholesterol-rich is by the following was increased in the LDLR mice in which the LDL clearance was was in the plasma of mice after the intravenous injection of Triton activity, which is with P.H. Inhibition of hepatic in a Thromb. PubMed Google Scholar, A. A. G. Inhibition of cholesterol lipoprotein from Lipid Res. Full Text PDF PubMed Google Scholar, of in the control of hepatic lipoprotein and lipoprotein receptor expression in the mouse and Biol. Chem. 2000; Full Text Full Text PDF PubMed Google Scholar), was an in using that the of cholesterol and the was increased the overexpressed SS this it is to that SS not statins, from the liver T. E. H. of a squalene synthase inhibitor, in vivo and in J. 2003; PubMed Scopus Google Scholar, T. H. H. H. a novel squalene synthase inhibitor, biosynthesis and in J. 2003; PubMed Scopus Google Scholar, H. Yanagimachi M. Ito M. N. T. H. D. Tanaka N. Yoshida I. et synthase inhibitors biosynthesis through the pathway in rat Lipid Res. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). These the that nonsterol mevalonate for or cholesterol H. Yanagimachi M. Ito M. N. T. H. D. Tanaka N. Yoshida I. et synthase inhibitors biosynthesis through the pathway in rat Lipid Res. 2003; Full Text Full Text PDF PubMed Scopus Google this LDL clearance may to the development of because the mRNA expression of the LDLR gene is The downregulation of the LDLR gene from the feedback regulation by the increased cholesterol biosynthesis. SS inhibitors the LDLR activity H. Yanagimachi M. Ito M. Ohtsuka I. Yoshida I. Saeki T. Tanaka H. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: with 3-hydroxy-3-methylglutaryl-CoA reductase Lipid Res. 2000; Full Text Full Text PDF PubMed Google Scholar, T. E. H. of a squalene synthase inhibitor, in vivo and in J. 2003; PubMed Scopus Google Scholar). is of that cholesterol of not increase in the liver the increased cholesterol to cholesterol was not in mice or the control of the in which cholesterol is stimulated by the overexpression of the form of SREBPs and which of cholesterol in the liver H. I. Brown M.S. Goldstein J.L. of cholesterol and liver in mice truncated Clin. Invest. PubMed Scopus Google Scholar, H. I. Brown M.S. Goldstein J.L. of sterol regulatory element binding is in livers of mice and in Clin. Invest. 1997; PubMed Scopus Google Scholar, I. Brown M.S. Goldstein J.L. H. of cholesterol in to in liver and of mice sterol regulatory Clin. Invest. PubMed Google Scholar). for this may that the of the increase in cholesterol was not to a of cholesterol in the because the was not increased cholesterol the lipoprotein without an increased hepatic may another may the transcription of genes that in genes involved in A is that cholesterol is of the liver the in for the increased the expression of genes for this such as cholesterol was not A is that cholesterol may for the plasma of cells. The liver was with an increased number of for after with that the in a the are in the expression of and proteins R.J. of mevalonate and of and Biol. Chem. Full Text Full Text PDF PubMed Scopus Google or in the cholesterol of J.A. R.G. M. R.G. et mice are evidence of and Biol. Chem. Full Text Full Text PDF PubMed Scopus Google may The that upregulation of SS may to hypercholesterolemia. in the SS gene that of activity may of hypercholesterolemia. with of SS, which is in this of hepatic SS activity the for the regulatory in the cholesterol biosynthetic pathway and for novel for S. and Goldstein for the of the HMG-CoA reductase, for and for was in by a for from the of and SS cDNA the control of endoplasmic reticulum LDL receptor of sterol-regulatory element binding squalene synthase cholesterol end
No takes yet. Share an insight, caveat, or question.
Okazaki et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: